Your browser doesn't support javascript.
loading
A miR-340/SPP1 axis inhibits the activation and proliferation of hepatic stellate cells by inhibiting the TGF-ß1/Smads pathway.
Zhang, Ronghua; Wang, Meimei; Lu, Hongjian; Wang, Jingyao; Han, Xiangyang; Liu, Zhiyong; Li, Lin; Li, Mingming; Tian, Xiaoli; Chen, Shuang; Zhang, Guangling; Xiong, Yanan; Li, Jingwu.
Afiliación
  • Zhang R; Hebei Key Laboratory for Chronic Diseases, School of Basic Medical Sciences, North China University of Science and Technology, Tangshan, China.
  • Wang M; Hebei Key Laboratory for Chronic Diseases, School of Basic Medical Sciences, North China University of Science and Technology, Tangshan, China.
  • Lu H; Hebei Key Laboratory for Chronic Diseases, School of Basic Medical Sciences, North China University of Science and Technology, Tangshan, China.
  • Wang J; School of Clinical Medicine, North China University of Science and Technology, Tangshan, China.
  • Han X; Hebei Key Laboratory for Chronic Diseases, School of Basic Medical Sciences, North China University of Science and Technology, Tangshan, China.
  • Liu Z; Health Science Center, North China University of Science and Technology, Tangshan, China.
  • Li L; Hebei Key Laboratory for Chronic Diseases, School of Basic Medical Sciences, North China University of Science and Technology, Tangshan, China.
  • Li M; Hebei Key Laboratory for Chronic Diseases, School of Basic Medical Sciences, North China University of Science and Technology, Tangshan, China.
  • Tian X; Gastroenterology Department, Tangshan Paraplegia Sanatorium, China.
  • Chen S; Tianjin Key Laboratory of Early Druggability Evaluation of Innovative Drugs, Tianjin International Joint Academy of Biomedicine, China.
  • Zhang G; School of Clinical Medicine, North China University of Science and Technology, Tangshan, China.
  • Xiong Y; Hebei Key Laboratory for Chronic Diseases, School of Basic Medical Sciences, North China University of Science and Technology, Tangshan, China.
  • Li J; The Cancer Institute, Hebei Key Laboratory of Molecular Oncology, Tangshan People's Hospital, China.
Adv Clin Exp Med ; 32(4): 469-479, 2023 Apr.
Article en En | MEDLINE | ID: mdl-36413180
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: MicroARNs / Factor de Crecimiento Transformador beta1 Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Adv Clin Exp Med Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Polonia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: MicroARNs / Factor de Crecimiento Transformador beta1 Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Adv Clin Exp Med Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Polonia